Application of comprehensive evaluation framework to Coronavirus Disease 19 studies: A systematic review of translational aspects of artificial intelligence in health care

Author:

Casey AaronORCID,Ansari SabaORCID,Nakisa BaharehORCID,Kelly BlairORCID,Brown Pieta,Cooper PaulORCID,Muhammad ImranORCID,Livingstone Steven,Reddy SandeepORCID,Makinen Ville-Petteri

Abstract

AbstractBackgroundDespite immense progress in artificial intelligence (AI) models, there has been limited deployment in healthcare environments. The gap between potential and actual AI applications is likely due to the lack of translatability between controlled research environments (where these models are developed) and clinical environments for which the AI tools are ultimately intended.ObjectiveWe have previously developed the Translational Evaluation of Healthcare AI (TEHAI) framework to assess the translational value of AI models and to support successful transition to healthcare environments. In this study, we apply the TEHAI to COVID-19 literature in order to assess how well translational topics are covered.MethodsA systematic literature search for COVID-AI studies published between December 2019-2020 resulted in 3,830 records. A subset of 102 papers that passed inclusion criteria were sampled for full review. Nine reviewers assessed the papers for translational value and collected descriptive data (each study was assessed by two reviewers). Evaluation scores and extracted data were compared by a third reviewer for resolution of discrepancies. The review process was conducted on the Covidence software platform.ResultsWe observed a significant trend for studies to attain high scores for technical capability but low scores for the areas essential for clinical translatability. Specific questions regarding external model validation, safety, non-maleficence and service adoption received failed scores in most studies.ConclusionsUsing TEHAI, we identified notable gaps in how well translational topics of AI models are covered in the COVID-19 clinical sphere. These gaps in areas crucial for clinical translatability could, and should, be considered already at the model development stage to increase translatability into real COVID-19 healthcare environments.

Publisher

Cold Spring Harbor Laboratory

Reference28 articles.

1. Artificial Intelligence: Promise, Pitfalls, and Perspective;JAMA,2020

2. Artificial intelligence-enabled healthcare delivery;J R Soc Med,2019

3. United States Government Accountability Office. Artificial Intelligence in Health Care: Benefits and Challenges of Technologies to Augment Patient Care | U.S. GAO. Artif Intell Health Care Benefits Chall Technol Augment Patient Care. 2020. Available from: https://www.gao.gov/products/gao-21-7sp [accessed Jul 13,2022]

4. Clinical artificial intelligence quality improvement: towards continual monitoring and updating of AI algorithms in healthcare;Npj Digit Med,2022

5. Evaluating Artificial Intelligence Applications in Clinical Settings;JAMA Netw Open United States,2018

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Çeviribiliminin Yapay Zeka (YZ) ile Geliştirilmesi: Zorluklar, İmkânlar ve Öneriler;Karamanoğlu Mehmetbey Üniversitesi Uluslararası Filoloji ve Çeviribilim Dergisi;2023-12-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3